●Research Activities and Accomplishments:

1. Gene therapy for malignant brain tumor with promoting apoptosis and anti-angiogenesis by a novel double-stranded adeno-associated viral (AAV) vector


2. Gene therapy for malignant brain tumor by anti-angiogenesis and apoptosis strategies with a novel double stranded adeno-associated viral vector in a human glioma-nude mice animal model


3. Proteomic analysis in gene therapeutic brain injury


4. Gene therapy for malignant brain tumor with antiangiogenesis strategy (angiostatin and endostatin)


5. Gene therapy for malignant brain tumor with apoptosis-enhancing strategy by a novel double-stranded adeno-associated viral (AAV) vector


6. Assessing the Therapeutic Effect of Recombinant Adeno-associated Virus-Glial Cell Line-derived Neurotrophic Factors (rAAV-GDNF) in Spinal Cord Injury Animal Mode


7. The Prevalence, Causes Analysis, Cohort Study and Implementation of Preventive Measures for Occupation-Related Musculoskeletal Disorders in Neurosurgical Staffs in TSGH (I-III)


8. Immune-based gene therapy of malignant brain tumor with a novel double-stranded type 2 Adeno-associated viral (AAV) vector carrying the IL-12, IL-23 and IL-27 genes in a syngeneic GL261/ C57BL/6 mice model


9. Engineered Opioid Receptors as Therapeutic Agent for Pain Control



 

 

 

 

 

 

 

上一頁